STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
STAT News · LC · trust 35/100
Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.
Read the original at STAT News →
Open in TruthVane →